Distribution of the receptor for a novel peptide stimulating phosphoinositide hydrolysis in human leukocytes

Clinical Biochemistry

Volumn 31, Issue 3, 1998, Pages 137-141

  Seo, Jeong Kon ^a,d   Bae, Yoe Sik ^a   Song, Hebok ^a   Baek, Suk Hwan ^a,e   Kim, Byung Sam ^b   Choi, Wan Sung ^c   Suh, Pann Ghill ^a   Ryu, Sung Ho ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b University of Ulsan   (South Korea)

^c Gyeongsang National University   (South Korea)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^e Yeungnam University College of Medicine   (South Korea)

Author keywords

B lymphocyte; Calcium; Peptides; Phospholipase C; Receptor

Indexed keywords

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOCHEMISTRY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROLYSIS; LEUKOCYTE; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; B-LYMPHOCYTES; CALCIUM; HUMANS; HYDROLYSIS; OLIGOPEPTIDES; PHOSPHATIDYLINOSITOLS; RECEPTORS, PEPTIDE; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0032052701     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00172-0     Document Type: Article

References (19)

1. 1. Springer TA. Traffic signals for lymphocytes recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301-14.
2. 2. Prieschl EE, Kulmburg PA, Baumruker T. The nomenclature of chemokines. Int Arch Allergy Immunol 1995; 107: 475-83.
3. 3. Bokoch GM. Chemoattractant signaling and leukocyte activation. Blood 1995; 86: 1649-60.
4. 4. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science 1984; 225: 1365-70.
5. 5. Berridge MJ, Irvine RF. Inositol phosphates and cell signaling. Nature 1989; 341: 197-205.
6. 6. Blank JL, Brattain KA, Exton JH. Activation of cytosolic phosphoinositide phospholipase C by G-protein beta gamma subunits. J Biol Chem 1992; 267: 23069-75.
7. 7. Katz A, Wu D, Simon HI. Subunits beta gamma of heterotrimeric G protein activates beta 2 isoform of phospholipase C. Nature 1992; 360: 686-9.
8. 8. Rossi F. The O2-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochem Biophys Acta 1986; 853: 65-89.
9. 9. McPhail LC, Clayton CC, Snyderman R. The NADPH oxidase of human polymorphonuclear leukocytes. Evidence for regulation by multiple signals. J Biol Chem 1984; 259: 5768-75.
10. 10. Baek SH, Seo JK, Chae CB, Suh PG, Ryu SH. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem 1996; 271: 8170-5.
11. 11. Seo JK, Choi SY, Kim Y, et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol 1997; 158: 1895-901.
12. 12. Severson CD, Bung DL, Lafrenz DE, Feldbush TL. An alternative method of panning for rat B lymphocytes. Immunol Lett 1987; 15: 291-5.
13. 13. Pember SO, Shapina R, Kinkade JM. Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure. Arch Biochem Biophys 1983; 221: 391-403.
14. 14. Yem AW, Zurcher HA, Richard KA, et al. Biotinylation of reactive amino groups in native recombinant human interleukin-1β. J Biol Chem 1989; 264: 17691-7.
15. 2 purinoceptors in PC12 cells. Br J Pharmacol 1995; 64: 1071-9.
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
17. 17. Maruo T, Ladines-Llave CA, Samoto T, et al. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology 1993; 132: 924-31.
18. 18. Sullivan R, Griffin JD, Malech HL. Acquisition of formyl peptide receptors during normal human myeloid differentiation. Blood 1987; 70: 1222-4.
19. 19. Murphy PM, McDermott D. Functional expression of the human formyl peptide receptor or Xenopus oocytes requires a complementary human factor. J Biol Chem 1991; 266: 12560-7.